# Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial

> **NCT07482917** · NA · RECRUITING · sponsor: **Hospital de Granollers** · enrollment: 92 (estimated)

## Conditions studied

- Interstitial Lung Disease (ILD)
- Suspected Interstitial Lung Disease
- Fibrotic Interstitial Lung Disease
- Idiopathic Pulmonary Fibrosis (IPF)
- Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)

## Interventions

- **OTHER:** Standard ILD Diagnostic Pathway
- **OTHER:** Optimized ILD Diagnostic Circuit

## Key facts

- **NCT ID:** NCT07482917
- **Lead sponsor:** Hospital de Granollers
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-09
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07482917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07482917, "Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07482917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*